Jiayi Wu

2PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 04, 2024
Case report: Emerging BRCA mutation confers benefit from olaparib after chemotherapy intolerance in advanced triple-negative breast cancer.

Xia-Bo Shen, Jia-Yi Wu, Jia-Ying Li

|Mar 14, 2024
Cyclin-dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple-negative breast cancer by affecting the immune microenvironment.

Jiayi Wu, Wei Wang, Lu Gao

Pageof 1

Frequent Collaborators

1 joint publications

Jia-Ying Li

1 joint publications

Wei Wang

1 joint publications

Lu Gao

1 joint publications

Xiying Shao